The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
Open accessAbstract
OCH, a sphingosine-truncated analog of α-galactosylceramide (αGC), is a potential therapeutic reagent for a variety of Th1-mediated autoimmune diseases through its selective induction of Th2 cytokines from natural killer T (NKT) cells.We demonstrate here that the NKT cell production of IFN-γ is more susceptible to the sphingosine length of glycolipid ligand than that of IL-4 and that the length of the sphingosine chain determines the duration of NKT cell stimulation by CD1d-associated glycolipids.Furthermore, IFN-γ production by NKT cells requires longer T cell receptor stimulation than is required for IL-4 production by NKT cells stimulated either with immobilized mAb to CD3 or with immobilized "αGC-loaded" CD1d molecules.Interestingly, transcription of IFN-γ but not that of IL-4 was sensitive to cycloheximide treatment, indicating the intrinsic involvement of de novo protein synthesis for IFN-γ production by NKT cells.Finally, we determined c-Rel was preferentially transcribed in αGC-stimulated but not in OCH-stimulated NKT cells and was essential for IFN-γ production by activated NKT cells.Given the dominant immune regulation by the remarkable cytokine production of ligand-stimulated NKT cells in vivo, in comparison with that of (antigen-specific) T cells or NK cells, the current study confirms OCH as a likely therapeutic reagent for use against Th1-mediated autoimmune diseases and provides a novel clue for the design of drugs targeting NKT cells.Methods Mice.C57BL/6 (B6) mice were purchased from CLEA Laboratory Animal Corp. (Tokyo, Japan).MHC class II-deficient I-A b β -/-mice were purchased from Taconic (Germantown, New York, USA).All animals were kept under specific pathogen-free conditions and were used at 7-10 weeks of age.Animal care and use were in accordance with institutional guidelines.Cell lines, antibodies, plasmids, and reagents.The NKT cell hybridoma (N38.2C12)(10) was a generous gift from K. Hayakawa (Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA) and NS0-derived Nonstandard abbreviations used: altered glycolipid ligand (AGL); altered peptide ligand (APL); CD28 responsive element (CD28RE); collagen-induced arthritis (CIA); c-Rel lacking C-terminal transactivation domain (c-RelΔTA); cycloheximide (CHX); cyclosporin A (CsA); experimental autoimmune encephalomyelitis (EAE); α-galactosylceramide (αGC); natural killer T (NKT); nuclear factor of activated T cell (NF-AT); phycoerythrin (PE); T cell receptor (TCR). Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Cited by
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Regulation of Interferon‐γ During Innate and Adaptive Immune Responses
(2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,655
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system
Matsuda, J. L., Mallevaey, T., Scott-Browne, J., & Gapin, L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.018 · Cited by 407
Metadata
- Authors
- Oki, S., Chiba, A., Yamamura, T., & Miyake, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-06-01
- Volume
- 113
- Issue
- 11
- Pages
- 1631-1640
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4242870036
- Cited by
- 232
- References
- 1
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.